Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Neuropathix
AddedFeb 19, 2024
UpdatedJun 18, 2026
Neuropathix

Neuropathix

Public

Neuropathix: An American biopharmaceutical firm specializing in R&D of pain management therapies.

HQ
Doylestown, PA, US
Founded
2010
Overview
Compare
Employees
Website

Neuropathix, Inc. is a biopharmaceutical company founded by Dean Petkanas and Thoma Kikis, headquartered in Doylestown, Pennsylvania. The company is dedicated to the research and development of next-generation therapeutics focused on pain management and neuroprotection. Neuropathix aims to address significant unmet medical needs by targeting inflammation through its innovative drug pipeline. Their products and services are designed to provide breakthrough treatments for patients suffering from chronic pain and neurodegenerative conditions.

Notable figures associated with Neuropathix include its founders, Dean Petkanas and Thoma Kikis. The company has achieved significant milestones, including securing patents (US 9611213, US 10004722) and receiving grant awards from the NIH-NINDS. Neuropathix's lead drug candidate, KLS-13019, has shown promising preclinical results, positioning the company as a key player in the biopharmaceutical industry. Their impact is marked by their commitment to advancing pain management therapies and contributing to the broader field of neuroprotective treatments.

Neuropathix - Similar Companies

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Neurolixis logo

Neurolixis

neurolixis.com

Neuraly logo

Neuraly

neuralymed.com

NeuroTherapia logo

NeuroTherapia

neurotherapia.com

Neuropore Therapies logo

Neuropore Therapies

neuropore.com

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

NeurOp logo

NeurOp

Neurovia logo

Neurovia

Pharmatrophix logo

Pharmatrophix

pharmatrophix.com

Neuros Medical logo

Neuros Medical

neurosmedical.com

Kannalife Sciences logo

Kannalife Sciences

kannalife.com

Nerx Biosciences logo

Nerx Biosciences

Neuraptive Therapeutics logo

Neuraptive Therapeutics

neuraptive.com

Aptinyx logo

Aptinyx

aptinyx.com

Neurodon logo

Neurodon

neurodon.net

Neuropathix - Quick Facts

Who are Neuropathix's competitors?

Companies similar to Neuropathix include NeuroTherapeutics Pharma, Neurolixis, Neuraly and NeuroTherapia.

When was Neuropathix founded?

Neuropathix was founded in 2010.

Where is Neuropathix's headquarters located?

Neuropathix's headquarters is located in Doylestown, PA, US.

How many employees does Neuropathix have?

Neuropathix has 3 employees as of Feb 5, 2024.

Neuropathix - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
  • Research
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 28 more industry codes
NAICS
  • 334600Manufacturing and Reproducing Magnetic and Optical Media
  • 513200Software Publishers
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 330000Manufacturing
  • 510000Information
  • 620000Health Care and Social Assistance
  • 334000Computer and Electronic Product Manufacturing
  • 513000Publishing Industries
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 334610Manufacturing and Reproducing Magnetic and Optical Media
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 6000Depository Institutions
  • 7300Business Services
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 1820Reproduction of recorded media
  • 5820Software publishing